Skip to content

DOKTER BART DE TROYER, UROLOOG

Active
Private limited companyfounded 201214 yrs activeHoogstraat 177, 9100 Sint-Niklaas, BelgiumKBO/BCE: BE 0844.861.486

DOKTER BART DE TROYER, UROLOOG has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.68M and a net result of €366k. Equity is growing by ~20.6% per year across the filed fiscal years. Its solvency ranks better than 92% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
95 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability95▼-1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €150k at 30 days acceptable
Liquidity ample (current ratio 21.12 against 7.16 in 2024; short-term debt: 4.3% and cash: 29.4% of total assets), and 4.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
95.7%
Return on assets
20.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 14 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-09-2026, 40 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
40 d late
2024
65 d late
2023
60 d late
2022
117 d late
2021
61 d late
2020
30 d late
2019
31 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€1.68M▲ 10.5%
2024 · €1.52M
2018: €258k 2019: €472k 2020: €701k 2021: €899k 2022: €1.13M 2023: €1.33M 2024: €1.52M
2018 → 2025
Total assets
€1.75M▲ 1.5%
2024 · €1.73M
2018: €474k 2019: €665k 2020: €870k 2021: €1.06M 2022: €1.35M 2023: €1.60M 2024: €1.73M
2018 → 2025
Net result
€366k▼ 2.2%
2024 · €375k
2018: €241k 2019: €217k 2020: €258k 2021: €267k 2022: €232k 2023: €255k 2024: €375k
2018 → 2025
Working capital
€1.52M▲ 17.7%
2024 · €1.29M
2018: €105k 2019: €331k 2020: €556k 2021: €746k 2022: €917k 2023: €1.14M 2024: €1.29M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€899k-€1.13M▲ 25.8%€1.33M▲ 17.4%€1.52M▲ 14.2%€1.68M▲ 10.5%
Operating result€378k-€340k▼ 10.1%€375k▲ 10.2%€521k▲ 38.9%€465k▼ 10.7%
Net result€267k-€232k▼ 12.8%€255k▲ 9.7%€375k▲ 47.0%€366k▼ 2.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400k€600kOperating result 2021: €378k€378kNet result 2021: €267k€267kOperating result 2022: €340k€340kNet result 2022: €232k€232kOperating result 2023: €375k€375kNet result 2023: €255k€255kOperating result 2024: €521k€521kNet result 2024: €375k€375kOperating result 2025: €465k€465kNet result 2025: €366k€366k20212022202320242025
The operating result falls in 2025; 2025 is 11% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.75M
Fixed assets €160k▼ 29.9%
Current assets €1.59M▲ 6.3%
Equity and liabilities €1.75M
Equity €1.68M▲ 10.5%
Debt €75k▼ 63.9%
The debt ratio falls from 12.1% to 4.3%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€502k
2024 · €565k
Cash flow
€403k
2024 · €419k
Solvency
95.7%
2024 · 87.9%
Current ratio
21.12
2024 · 7.16
Quick ratio
21.12
2024 · 7.16
Debt / equity
0.04
2024 · 0.14
ROE
21.9%
2024 · 24.7%
ROA
20.9%
2024 · 21.7%
Interest coverage
212.97
2024 · 85.37
Debt
€75k
2024 · €209k
Debt ≤ 1 year
€75k
2024 · €209k
Income taxes
€165k
2024 · €169k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.73M€1.75M
Fixed assets21/28€228k€160k
Tangible fixed assets22/27€228k€160k
Land and buildings22€101k€87k
Plant, machinery and equipment23€19k€12k
Furniture and vehicles24€109k€62k
Current assets29/58€1.50M€1.59M
Amounts receivable within one year40/41€34k€55k
Trade receivables40€3k€3k
Other amounts receivable41€31k€52k
Current investments50/53€674k€818k
Cash at bank and in hand54/58€626k€515k
Deferred charges and accrued income490/1€164k€204k
Equity and liabilities
Total equity and liabilities10/49€1.73M€1.75M
Equity10/15€1.52M€1.68M
Contributions10/11€20k€20k=
Reserves13€1.50M€1.66M
Distributable reserves133€1.50M€1.66M
Profit (loss) carried forward14-€0
Amounts payable17/49€209k€75k
Amounts payable within one year42/48€209k€75k
Current portion of amounts payable after more than one year42€48k€34k
Trade debts44€3k€4k
Suppliers440/4€3k€4k
Taxes, remuneration and social security45€158k€38k
Taxes450/3€158k€38k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44k€37k
Other operating charges640/8€1k€6k
Gross operating margin9900€566k€508k
Operating profit (loss)9901€521k€465k
Financial income75/76B€29k€69k
Recurring financial income75€29k€69k
Financial charges65/66B€7k€2k
Recurring financial charges65€7k€2k
Profit (loss) for the period before taxes9903€544k€532k
Income taxes67/77€169k€165k
Profit (loss) for the period9904€375k€366k
Profit (loss) for the period to be appropriated9905€375k€366k
Appropriation of the result
Profit (loss) to be appropriated9906€375k€366k
Transfer from equity791/2€186k€207k
Transfer to equity691/2€375k€366k
To other reserves6921€375k€366k
Profit to be distributed694/7€186k€207k
Return on contributions (dividend)694€186k€207k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
09-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 40 days late
2025
31-12
Financial Liquidity triplescurrent ratio 21.12
Current ratio from 7.16 to 21.12; short-term debt falls from €209k to €75k.
04-10
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 65 days late
2024
31-12
Financial Highest result since 2018net €375k ▲47%
Operating result €521k, net result €375k, both a record.
29-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 60 days late
2023
25-11
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 117 days late
2022
31-12
Financial Equity above €1MEq €1.13M ▲25.8%
5 profitable years in a row build equity to €1.13M.
30-09
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 61 days late
2021
30-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-12
Financial Equity above €500kEq €701k ▲48.7%
3 profitable years in a row build equity to €701k.
31-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
2019
31-12
Financial Weakest financial yearnet €217k ▼10%
Net result drops to €217k, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity triplescurrent ratio 5.10
Current ratio from 1.94 to 5.10; short-term debt falls from €112k to €81k.
27-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
11-09
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 42 days late
2017
03-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 3 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Niklaas · 1 establishment unit since 2012
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Hoogstraat 1779100 Sint-Niklaas
Ground area
2,888 m²
Building footprint
281 m²
Volume, LiDAR
1,553 m³
Parcel 46021A0071/00A000, Flanders · tallest building 10.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DOKTER BART DE TROYER, UROLOOG
Hoogstraat 177, 9100 Sint-NiklaasSpecialist medical practice
since 20122.208.845.594
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
46021A0071/00A000 Flanders 2,888 m² 1 · 281 m² 10.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 4,977 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded30-03-2012
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.